Why this income stock is outperforming its peers today

The Atlas Arteria Group (ASX: ALX) share price jumped and it isn't only its good full year results that's driving the stock.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Atlas Arteria Group (ASX: ALX) share price is defying the broader market gloom after management said it would pay out a better than expected dividend.

Shares in the toll road operator jumped 2.3% to $8.16 in late afternoon trade when the S&P/ASX 200 (Index:^AXJO) (ASX:XJO) index shed 0.7% of its value.

Fellow infrastructure stocks like the Transurban Group (ASX: TCL) share price and APA Group (ASX: APA) share price are also trading in the red as worries about the economic fallout from the growing coronavirus scare leave few places for investors to hide.

a woman

Overtaking lane

Atlas Arteria is proving to the exception even as worries of a virus outbreak in Europe and the US intensifies. The company's assets are in both continents.

But investors aren't bothered as management handed in its full year profit results that showed a near 9% increase in adjusted net profit to $178.2 million for 2019 (it's financial year ends in December).

The good result was driven by a 5.5% increase in profits from Atlas Arteria's stake in French toll road network APRR and Warnow Tunnel in Germany, while its US Dulles Greenway asset detracted.

Better than expected dividends

Management declared an 18 cent a share distribution to shareholders for the second half of 2019 and said it will pay a similar amount for the first half of 2020.

This represents a 6% increase in the company's previous guidance back in November and a 20% uplift in 2019 dividends.

The increase payout is a confidence booster for investors and reflects management's positive outlook for the group – notwithstanding the COVID-19 virus outbreak.

Reaping the rewards

"The 2019 year was a pivotal one for Atlas Arteria," said the company's chief executive Graeme Bevans.

"We built a new corporate team, managed a seamless transfer of management arrangements and, delivered strong underlying performance. We secured arrangements to increase Atlas Arteria's indirect interest in APRR and become a truly independent group."

Atlas Arteria paid $2.3 million in costs associated with internalising management of the assets. It also had to cough up $20.7 million to Macquarie Group Ltd (ASX: MQG) in fees under a transition agreement.

Foolish takeaway

Atlas Arteria spun out of Macquarie and the operations of the managed by the investment bank before the internalisation exercise.

Defensive income stocks have been well supported over the past year or two. Record low interest rates and an increasingly uncertain economic environment are driving interest in such investments. This trend is unlikely to wane in 2020.

Motley Fool contributor Brendon Lau owns shares of Macquarie Group Limited. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited and Transurban Group. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why Kingsgate, Neuren, Newcrest, and Pushpay shares are rising today

These ASX shares are avoiding the market selloff on Tuesday.

Read more »

A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
Share Gainers

Why Neuren, Northern Star, Race Oncology, and Westgold shares are storming higher

These ASX shares are starting the week in a positive fashion.

Read more »

A woman wearing yellow smiles and drinks coffee while on laptop.
Share Gainers

Why APM, Macquarie Telecom, Northern Star, and Origin shares are rising today

These ASX shares are having a strong session despite the market selloff.

Read more »

Two boys with cardboard rockets strapped to their backs, indicating two ASX companies with rocketing share prices
Share Gainers

Catch these fast-rising 2 ASX shares before it's too late: Celeste

This pair of stocks rocketed up in February during reporting season, but are still great value for those willing to…

Read more »

three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
Share Gainers

Why Arafura, Myer, Volpara, and Xero shares are zooming higher

These ASX shares are making their shareholders smile on Thursday.

Read more »

medical asx share price represented by doctor giving thumbs up
Healthcare Shares

Guess which ASX biotech stock just rocketed 29% on big FDA news

The ASX healthcare share is attracting investor interest following FDA approval for its targeted cancer therapy compound.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Mesoblast, PolyNovo, Pushpay, and Weebit Nano shares are charging higher

These ASX shares are having a strong session despite the market selloff.

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why InvoCare, Pentanet, Sayona Mining, and Weebit Nano shares are storming higher

These ASX shares are having a strong session on Tuesday.

Read more »